You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Protein NanoArray for Cytokine Profiling in Mouse Models

    SBC: BIOFORCE NANOSCIENCES, INC.            Topic: N/A

    DESCRIPTION (provided by the applicant): This is a Phase I SBIR proposal to test the feasibility of using an ultra miniaturized protein NanoArray for profiling cytokine expression in mouse model systems. BioForce Nanosciences, Inc., has developed proprietary technology for the construction of NanoArrays/TM, an ultra miniaturized assay platform that allows a thousand or more molecular tests to be ...

    SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  2. Microfabricated Deposition Tools for Creating NanoArrays

    SBC: BIOFORCE NANOSCIENCES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The goal of this proposal is to design and test novel microcantilever devices for the purpose of improving deposition of biomaterials in ultraminiaturized arrays. BioForce NanoSciences, Inc. (http://www.bioforcelab.com) is an industry leader in the development of next-generation biomolecular screening arrays, or NanoArrays, with patented technology permitting ...

    SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  3. Virtual Environment Tools for Assessing Fitness to Drive

    SBC: Digital Artefacts LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Automobile crashes pose a serious public health problem, and drivers with aging and age-related neurological and medical disorders are at increased risk for crashes due to cognitive impairment. Specific effects of cognitive disorders that increase the risk of driver crashes, such as impaired decision-making, can be assessed safely and in detail, under standardi ...

    SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  4. TERFENOL-D Lamination Process Cost Reduction

    SBC: Etrema Products, Inc.            Topic: N/A

    There are several key components to making efficient high performance TERFENOL-D actuators and sonar projectors. TERFENOL-D being a magnetically driven material requires magnetic materials and circuit design considerations.One of the principle considerations in a TERFENOL-D actuator is the lamination of the drive rod assembly to minimize eddy current generation. It has not been well investigated t ...

    SBIR Phase I 2003 Department of DefenseNavy
  5. TERFENOL-D Lamination Process Cost Reduction

    SBC: Etrema Products, Inc.            Topic: N/A

    There are several key components to making efficient high performance TERFENOL-D actuators and sonar projectors. TERFENOL-D being a magnetically driven material requires magnetic materials and circuit design considerations.One of the principle considerations in a TERFENOL-D actuator is the lamination of the drive rod assembly to minimize eddy current generation. It has not been well investigated t ...

    SBIR Phase II 2003 Department of DefenseNavy
  6. Development of a Sequencing Batch Biofilm Reactor for Treatment of Pesticide Rinsewater

    SBC: ARONORA INC            Topic: N/A

    NON-TECHNICAL SUMMARY: Pesticide formulation and agricultural-chemical facilities generate a dilute troublesome pesticide rinsewater that is difficult to dispose of due to its low volume, highly variable flow and the presence of a mixture of pesticides, solvents and emulsifiers. The sequencing batch biofilm reactor (SBBR) is expected to be a low-cost treatment technology for pesticide rinsewater. ...

    SBIR Phase I 2003 Department of Agriculture
  7. SBIR Phase I: Rapid Sensitive Diagnostic Technology Based On Novel Physical Principles

    SBC: Genetic ID NA            Topic: N/A

    This Small Business Innovation Research (SBIR) Phase I project is to develop a fluidic wave guide biosensor that employs unique physical and structural features to measure biological pathogens. Preliminary research indicates that this diagnostic technology promises to achieve a combination of speed, simplicity, sensitivity and selectivity significantly superior to that attained by current pathoge ...

    SBIR Phase I 2003 National Science Foundation
  8. Designing a Natural Soy Processing System that Delivers Nutritious Texturized Soy Protein

    SBC: SCHILLINGER SEED INC            Topic: N/A

    NON-TECHNICAL SUMMARY: Since the Food and Drug Administration announced in 1999 that foods containing soy protein may reduce the risk of coronary heart disease, commercial food companies have been looking for soy foods to meet customer demand for more healthful, convenient food. Development of appealing meat alternative products has been limited by existing equipment used to produce texturized soy ...

    SBIR Phase I 2003 Department of Agriculture
  9. Medication Dispenser: MD2: Improving Health Outcomes

    SBC: INTERACTIVE MEDICAL DEVELOPMENT, LC            Topic: N/A

    DESCRIPTION (provided by investigator): The medication dispensing and monitoring system, MD 2, has been shown in preliminary studies to support a medication compliance rate of 98.5% The MD 2 was developed by Interactive Medical Developments LC to address issues of medicine non-compliance and the negative impact non-compliance has on the health and well being of the patient and the frustration of c ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  10. Nutritional Intervention for Older Adult Muscle Loss

    SBC: MTI Biotech Incorporated            Topic: N/A

    DESCRIPTION (provided by applicant): Age-related muscle loss is a major public health issue affecting over 30 million Americans, with no viable treatments available to stem about an 8% loss in muscle mass every decade. Preliminary studies with beta-hydroxy-beta-methylbutyrate, arginine, and lysine (HMB/ARG/LYS) indicate a reversal of age-related muscle loss is possible, at least with women. Limit ...

    SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government